Amikacin is a semisynthetic aminoglycoside antibiotic, derived from kanamycin, with broad-spectrum activity. It is widely used in research to study antibacterial mechanisms and efficacy, both in vitro against resistant bacterial strains and in vivo within animal infection models.
